42 USC 2065 - Improving the reliability of domestic medical isotope supply

Editorial Notes

References in Text

This subtitle, referred to in subsec. (c)(5), is subtitle F (§§ 3171–3178) of title XXXI of div. C of Puspan. L. 112–239. For complete classification of this subtitle to the Code, see Short Title of 2013 Amendment note set out under section 2011 of this title and Tables.

Codification

Section was enacted as part of the American Medical Isotopes Production Act of 2012 and also as part of the National Defense Authorization Act for Fiscal Year 2013, and not as part of the Atomic Energy Act of 1954 which comprises this chapter.

Amendments

2021—Subsec. (a)(4)(B). Puspan. L. 117–81 substituted “triennial reviews” for “annual reviews”.

Statutory Notes and Related Subsidiaries

Definitions

Puspan. L. 112–239, div. C, title XXXI, § 3172, Jan. 2, 2013, 126 Stat. 2211, provided that: “In this subtitle [subtitle F (§§ 3171–3178), see Short Title of 2013 Amendment note set out under section 2011 of this title and Tables]:

“(1)Department.—The term ‘Department’ means the Department of Energy.

“(2)Highly enriched uranium.—The term ‘highly enriched uranium’ means uranium enriched to 20 percent or greater in the isotope U–235.

“(3)Low enriched uranium.—The term ‘low enriched uranium’ means uranium enriched to less than 20 percent in the isotope U–235.

“(4)Secretary.—The term ‘Secretary’ means the Secretary of Energy.”